Stay updated with breaking news from ஆக்ரீதி குப்தா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Women Share their Experience of Polycystic Ovarian Syndrome ‘Do not google too much, seek a proper consultation’ With the second wave of COVID-19 hitting the country, people are again being pushed into a state of uncertainties and anxieties. There have been numerous reports on how coping with COVID-19 has caused panic leading to increased stress. Along with many other consequences, severe stress can seriously impact a woman’s reproductive and menstrual health, leading to long-term health conditions. One such problem exacerbated by stress is Polycystic Ovarian Syndrome, generally referred to as PCOS. PCOS is a hormonal disorder affecting women of reproductive age. Common symptoms include infrequent or prolonged menstrual periods, acne and excessive hair growth. It affects the ovaries and leads to hormonal imbalances instigated by the production of male hormones called androgens. Reports suggest that cases of PCOS have been escalating all over the world. ....
New research suggests that people who use statins before hospitalization for COVID-19 were approximately 50% less likely to develop severe COVID-19 and die. ....
Statins may lessen the impact COVID-19, yet another retrospective, observational study hints. Early during the pandemic in New York City, patients who were already taking statins when they were admitted for COVID-19 were less likely to die in the hospital within the first 30 days than those who were not taking the medications (14.8% vs 26.5%; OR 0.47; 95% CI 0.36-0.62), researchers report. The proportion of patients who required invasive mechanical ventilation in the first 30 days was numerically lower in the statin group, although the difference fell shy of statistical significance (18.6% vs 21.9%; OR 0.76; 95% CI 0.58-1.00), according to findings published online February 26, 2021, in Nature Communications. More of TCTMD s coverage on our COVID-19 hub. ....
Statin use associated with reduction in mortality of patients with severe COVID-19 People who took statins to lower cholesterol were approximately 50% less likely to die if hospitalized for COVID-19, a study by physicians at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian has found. Our study is one of the larger studies confirming this hypothesis and the data lay the groundwork for future randomized clinical trials that are needed to confirm the benefit of statins in COVID-19, says Aakriti Gupta, MD, a cardiologist at NewYork-Presbyterian/Columbia University Irving Medical Center and one of the co-lead authors of the study. ....